Leslie J. Holsinger Ph.D.
Net Worth
Last updated:
What is Leslie J. Holsinger Ph.D. net worth?
The estimated net worth of Dr. Leslie J. Holsinger Ph.D. is at least $5,329,550 as of 14 Dec 2020. He owns shares worth $3,510 as insider, has earned $2,491,040 from insider trading and has received compensation worth at least $2,835,000 in Cortexyme, Inc..
What is the salary of Leslie J. Holsinger Ph.D.?
Dr. Leslie J. Holsinger Ph.D. salary is $567,000 per year as Executive Vice President of R&D in Cortexyme, Inc..
How old is Leslie J. Holsinger Ph.D.?
Dr. Leslie J. Holsinger Ph.D. is 60 years old, born in 1965.
What stocks does Leslie J. Holsinger Ph.D. currently own?
As insider, Dr. Leslie J. Holsinger Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Cortexyme, Inc. (CRTX) | Executive Vice President of R&D | 1,800 | $1.95 | $3,510 |
What does Cortexyme, Inc. do?
Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis, and coronavirus infection. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
Leslie J. Holsinger Ph.D. insider trading
Cortexyme, Inc.
Dr. Leslie J. Holsinger Ph.D. has made 3 insider trades in 2020, according to the Form 4 filled with the SEC. Most recently he sold 40,000 units of CRTX stock worth $1,245,520 on 14 Dec 2020.
The largest trade he's ever made was exercising 40,000 units of CRTX stock on 14 Dec 2020. As of 14 Dec 2020 he still owns at least 1,800 units of CRTX stock.
Cortexyme key executives
Cortexyme, Inc. executives and other stock owners filed with the SEC:
- Dr. Leslie J. Holsinger Ph.D. (60) Executive Vice President of R&D
- Dr. Michael J. Detke M.D., Ph.D. (58) Chief Medical Officer
- Mr. Christopher P. Lowe M.B.A. (54) Chief Operating Officer, Chief Financial Officer & Treasurer
- Ms. Caryn Gordon McDowell (55) Chief Legal & Admin. Officer and Corporation Sec.
- Ms. Casey C. Lynch (51) Co-Founder, Chairman, Pres & Chief Executive Officer